Chemical Drink may Help Heart Attack Patients by Giving Them an Energy Boost

A chemical drink is capable of increasing the supply of oxygen to the damaged cardiac muscle in heart attack patients, thus giving them an energy boost, according to a group of French researchers.

Jean-Marie Lehn and his colleagues, at the University of Strasbourg, came to this conclusion after carrying out experiments on ailing mice, wherein the drink-formed by dissolving the drug myo-inositol trispyrophosphate (ITPP) in water-boosted exercise levels in the animals by 35 per cent.

Chest pain – Causes – Risk Factors – Symptoms – Diagnosis – Treatment
Ask any one who has experienced intense chest pain and they will vouch for the fact that it was the most frightening experience of their life!

The researcher revealed that the drink had been designed to make haemoglobin release more of its oxygen than normal.

They said that when it was given by injection into the abdomen, the subjects' exercise levels rose a massive 60 per cent.

"ITPP doesn't deliver oxygen itself, but makes haemoglobin able to release a larger amount of oxygen to tissues," the Sun quoted Lehn as saying.

Heart Attack - Overview
Heart attack is the death of the heart muscle due to loss of blood supply. Heart disease is the leading cause of death in the United States. Other names for heart attack include acute myocardial infarction, coronary thrombosis, and coronary occlusion.

He revealed that haemoglobin generally releases only 25 per cent of oxygen during one circuit of the body. But when ITPP binds to haemoglobin, he adds, it releases 35 per cent more than usual, boosting supplies of oxygen to tissues without people having to inhale any extra air.

The researcher even said that the effect from a single dose was found to last for almost a week, which means that the patient need not take ITPP every day.

Animation on Coronary Artery Bypass Surgery (CABG)
Coronary Artery Bypass Surgery (CABG) is performed to restore the blood supply to areas of heart that have been reduced or has no blood supply due to blockage in the artery.

Though the substance is not natural, it is said to be related to myo-inositol, which is found in rice and cereals.

Lehn hopes to begin clinical trials on humans "as soon as possible".

He, however, warned athletes against using the substance to enhance their performance.

"It could be very easily detected," New Scientist magazine quoted him as saying.

Lehn revealed that his team were continuing their research to determine exactly how ITPP interferes with haemoglobin to make it give up more oxygen.

A report on Lehn's study has been published in the journal Proceedings of the National Academy of Sciences.

Source-ANI
SAV